Stephenson-Gussinye Aura, Rendón-Bautista Luis A, Ruiz-Medina Blanca E, Blanco-Olais Eduardo, Pérez-Molina Rosario, Marcial-Medina Cleofas, Chavarri-Guerra Yanin, Soto-Pérez-de-Celis Enrique, Morales-Alfaro Andrea, Esquivel-López Ayerim, Candanedo-González Fernando, Gamboa-Domínguez Armando, Cortes-González Rubén, Alfaro-Goldaracena Alejandro, Vázquez-Manjarrez Sara E, Grajales-Figueroa Guido, Astudillo-Romero Beatriz, Ruiz-Manriquez Jesús, Poot-Hernández A César, Licona-Limón Paula, Furlan-Magaril Mayra
Molecular Genetics Department, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico.
Department of Cellular and Developmental Biology, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico.
Front Mol Biosci. 2024 Aug 22;11:1420308. doi: 10.3389/fmolb.2024.1420308. eCollection 2024.
Molecular and cellular characterization of tumors is essential due to the complex and heterogeneous nature of cancer. In recent decades, many bioinformatic tools and experimental techniques have been developed to achieve personalized characterization of tumors. However, sample handling continues to be a major challenge as limitations such as prior treatments before sample acquisition, the amount of tissue obtained, transportation, or the inability to process fresh samples pose a hurdle for experimental strategies that require viable cell suspensions. Here, we present an optimized protocol that allows the recovery of highly viable cell suspensions from breast cancer primary tumor biopsies. Using these cell suspensions we have successfully characterized genome architecture through Hi-C. Also, we have evaluated single-cell gene expression and the tumor cellular microenvironment through single-cell RNAseq. Both technologies are key in the detailed and personalized molecular characterization of tumor samples. The protocol described here is a cost-effective alternative to obtain viable cell suspensions from biopsies simply and efficiently.
由于癌症具有复杂和异质性的特点,肿瘤的分子和细胞特征分析至关重要。近几十年来,人们开发了许多生物信息学工具和实验技术来实现肿瘤的个性化特征分析。然而,样本处理仍然是一个重大挑战,因为诸如样本采集前的预处理、获得的组织量、运输,或者无法处理新鲜样本等限制因素,给需要活细胞悬液的实验策略带来了障碍。在此,我们展示了一种优化方案,该方案能够从乳腺癌原发肿瘤活检样本中获得高活性的细胞悬液。利用这些细胞悬液,我们通过Hi-C成功地对基因组结构进行了特征分析。此外,我们还通过单细胞RNA测序评估了单细胞基因表达和肿瘤细胞微环境。这两种技术对于肿瘤样本的详细和个性化分子特征分析都至关重要。本文所述方案是一种经济高效的替代方法,可简单有效地从活检样本中获得活细胞悬液。